| 1 |
-
Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease
-
1/27/2026 10:12:32 AM | Browse: 32 | Download: 144
|
| 2 |
-
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
-
12/26/2025 10:27:34 AM | Browse: 63 | Download: 274
|
| 3 |
-
Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease
-
10/27/2025 10:57:53 AM | Browse: 185 | Download: 317
|
| 4 |
-
Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion
-
4/18/2025 8:22:26 AM | Browse: 101 | Download: 371
|
| 5 |
-
Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease
-
4/11/2025 2:19:32 AM | Browse: 136 | Download: 836
|
| 6 |
-
Prospects of elafibranor in treating alcohol-associated liver diseases
-
12/18/2024 7:36:02 AM | Browse: 143 | Download: 532
|
| 7 |
-
Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
-
10/21/2024 7:03:25 AM | Browse: 152 | Download: 484
|
| 8 |
-
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
-
12/6/2023 8:08:49 AM | Browse: 382 | Download: 1449
|
| 9 |
-
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
-
5/24/2023 9:31:05 AM | Browse: 416 | Download: 1288
|
| 10 |
-
Pancreatic fat in type 2 diabetes: Causal or coincidental?
-
3/1/2023 6:11:27 AM | Browse: 422 | Download: 1119
|
| 11 |
-
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
-
7/4/2022 12:30:52 PM | Browse: 593 | Download: 1455
|
| 12 |
-
Metabolic aspects of hepatitis C virus
-
6/10/2022 5:40:20 AM | Browse: 700 | Download: 1631
|
| 13 |
-
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
-
4/29/2022 11:12:04 AM | Browse: 718 | Download: 1416
|
| 14 |
-
Glycogen hepatopathy in type-1 diabetes mellitus: A case report
-
2/22/2022 9:25:38 AM | Browse: 591 | Download: 1369
|
| 15 |
-
Nonalcoholic fatty liver disease shows significant sex dimorphism
-
2/11/2022 5:55:19 AM | Browse: 635 | Download: 1780
|
| 16 |
-
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
-
1/21/2022 8:16:14 AM | Browse: 786 | Download: 1764
|
| 17 |
-
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
-
10/20/2021 7:18:39 AM | Browse: 716 | Download: 1246
|
| 18 |
-
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
-
9/7/2021 8:15:21 AM | Browse: 874 | Download: 1573
|
| 19 |
-
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
-
8/4/2021 7:56:20 AM | Browse: 662 | Download: 1995
|
| 20 |
-
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
-
7/12/2021 12:42:13 AM | Browse: 847 | Download: 1952
|
| 21 |
-
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
-
7/6/2021 2:31:17 AM | Browse: 751 | Download: 2139
|
| 22 |
-
Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
-
6/18/2021 5:06:16 AM | Browse: 768 | Download: 1921
|
| 23 |
-
Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients
-
5/8/2021 7:57:00 AM | Browse: 783 | Download: 1916
|
| 24 |
-
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
-
3/18/2021 10:54:40 AM | Browse: 931 | Download: 1600
|
| 25 |
-
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
-
2/5/2021 10:20:18 AM | Browse: 857 | Download: 2082
|
| 26 |
-
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
-
11/24/2020 12:41:21 PM | Browse: 887 | Download: 2201
|
| 27 |
-
Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
-
11/6/2020 7:36:12 AM | Browse: 913 | Download: 2559
|
| 28 |
-
Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis
-
9/4/2020 7:25:49 AM | Browse: 888 | Download: 2734
|
| 29 |
-
Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
-
8/7/2019 7:09:17 AM | Browse: 1125 | Download: 1803
|
| 30 |
-
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
-
7/28/2019 10:51:57 AM | Browse: 1057 | Download: 1498
|
| 31 |
-
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
-
6/28/2019 12:22:27 PM | Browse: 1338 | Download: 2567
|
| 32 |
-
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
-
3/20/2019 5:32:10 AM | Browse: 1423 | Download: 2319
|
| 33 |
-
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
-
2/26/2019 11:29:04 AM | Browse: 1377 | Download: 2111
|
| 34 |
-
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
-
1/21/2019 5:38:30 AM | Browse: 1304 | Download: 1815
|
| 35 |
-
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
-
1/14/2019 2:54:12 PM | Browse: 1512 | Download: 2282
|
| 36 |
-
Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
-
12/27/2018 8:56:32 AM | Browse: 1167 | Download: 2214
|
| 37 |
-
Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
-
9/25/2018 3:44:36 AM | Browse: 1310 | Download: 2136
|
| 38 |
-
Feasibility of using marginal liver grafts in living donor liver transplantation
-
6/15/2018 9:13:16 AM | Browse: 1442 | Download: 1882
|
| 39 |
-
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
-
4/27/2018 3:25:40 AM | Browse: 1547 | Download: 1906
|
| 40 |
-
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
-
3/16/2018 12:27:25 PM | Browse: 1561 | Download: 2785
|
| 41 |
-
circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
-
1/19/2018 9:46:49 AM | Browse: 1398 | Download: 2206
|
| 42 |
-
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
-
6/20/2017 12:12:52 PM | Browse: 1465 | Download: 2282
|
| 43 |
-
Non-alcoholic fatty liver disease: An expanded review
-
6/6/2017 12:54:56 AM | Browse: 1743 | Download: 1977
|
| 44 |
-
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
-
5/20/2017 12:26:24 PM | Browse: 1545 | Download: 1951
|
| 45 |
-
Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice
-
5/16/2017 6:56:36 AM | Browse: 1603 | Download: 2955
|
| 46 |
-
Non-alcoholic fatty liver disease and cardiovascular risk
-
5/16/2017 6:56:36 AM | Browse: 1641 | Download: 1850
|
| 47 |
-
Changes in human hepatic metabolism in steatosis and cirrhosis
-
4/20/2017 3:58:56 PM | Browse: 1913 | Download: 3058
|
| 48 |
-
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
-
1/19/2017 11:16:00 AM | Browse: 1769 | Download: 2630
|
| 49 |
-
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
-
12/27/2016 8:31:00 AM | Browse: 1798 | Download: 3256
|
| 50 |
-
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
-
11/26/2016 6:56:00 PM | Browse: 1654 | Download: 2292
|
